/content/mofsl-website-adobe/fragments/open-demat-popup

style

hide-in-desktop

Neuraxis Inc share price today is $6.48, up 0.47%. The stock opened at $6.32 against the previous close of $6.45, with an intraday high of $6.78 and low of $6.31.

style

pb-0

Neuraxis Inc

/content/mofsl-website-adobe/demat-form-fields

style

sticky-block,pt-0

us-stock

style

pt-0

$6.48 0.0047(0.47%) NRXS at 13 Mar 2026 02:30 PM Biotechnology

Lowest Today 6.31

Highest Today 6.78

Today’s Open 6.32

Prev. Close 6.45

52 Week High 6.80

52 Week Low 1.33

Day’s Range: Low 6.31 High 6.78

52-Week Range: Low 1.33 High 6.80

Neuraxis Inc Institutional Holdings

Neuraxis Inc Market Status

Strong Buy: 1

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

Neuraxis Inc Fundamentals

Market Cap 66.47 M

PB Ratio 29.4686

PE Ratio 0.0

Enterprise Value 63.32 M

Total Assets 4.76 M

Volume 90436

Neuraxis Inc Company Financials

Annual Revenue FY23:2541672 2.5M, FY22:2684735 2.7M, FY21:2721286 2.7M, FY20:1930228 1.9M

Annual Profit FY23:2235458 2.2M, FY22:2387675 2.4M, FY21:2253630 2.3M, FY20:1449139 1.4M

Annual Net worth FY23:-9327006 -9.3M, FY22:-4780061 -4.8M, FY21:-3073232 -3.1M, FY20:-4050212 -4.1M

Quarterly Revenue Q3/2025:811414 0.8M, Q2/2025:894086 0.9M, Q1/2025:895655 0.9M, Q3/2024:666625 0.7M, Q2/2024:611500 0.6M

Quarterly Profit Q3/2025:675927 0.7M, Q2/2025:747443 0.7M, Q1/2025:756180 0.8M, Q3/2024:569575 0.6M, Q2/2024:538042 0.5M

Quarterly Net worth Q3/2025:-2122796 -2.1M, Q2/2025:-1690418 -1.7M, Q1/2025:-2278684 -2.3M, Q3/2024:-1755234 -1.8M, Q2/2024:-2917710 -2.9M

About Neuraxis Inc & investment objective

Company Information NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. The company offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8-21 years of age with functional abdominal pain associated with irritable bowel syndrome. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana.

Organisation Biotechnology

Employees 21

Industry Biotechnology

CEO Mr. Brian Carrico

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*